BLRX | BioLineRx, Ltd.
Next ER: May 24, 2023 Before Market Opens
About the Company
BioLineRx, or BioLine, is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
NASDAQ - Nasdaq Stock Market
More profiles and info about the company
This company doesn't provide a dividend.
Talk about BioLineRx, Ltd. below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.